Klas Arildsson
Chairman of the Board since 2020

Klas Arildsson has extensive experience in global operations, medical device and life science. Most recently he served as VP Operations Getinge Infection Control AB and previously led business areas for two other medical device companies as Senior VP of Global Supply Chain at Gambro Renal Products and VP Supply Chain Manufacturing at Baxter Inc. Additional past roles include VP of Operations at Cardo Door and Quality Manager and Plant Manager at Ericsson Telecom. Previous Board assignments include Gambro Lundia AB, Lund Nyföretagarcentrum and Life Assays AB.

  • Other appointments: Chairman of the Board Kristianstad Österlen Airport, Board member of Redsense Medical AB, and member of Lund University’s Business Council.
  • Education: Mr. Arildsson completed the KTH Royal Institute of Technology Executive Management Program.
  • Born: 1960
  • Holdings: 154 286 shares
  • Independence: Dependent in relation to the company and the company’s senior executives and Independent to the major shareholders of the company.

Richard DiIorio
Board member since 2020

Richard DiIorio

Richard DiIorio is President & CEO of InfuSystem Holdings (INFU), a leading U.S. healthcare company providing medical devices and services to hospitals, home infusion providers, oncology practices and patients. He has a strong track record of accomplishment with more than 20 years of medical sales experience, expertise in product launch, and industry knowledge focused on driving growth in the oncology market. Previously he held various sales and sales leadership roles at Stryker Medical, Novartis Pharmaceuticals, and Thermo Scientific.

  • Other appointments:  Director, InfuSystem Holdings
  • Education: Mr. DiIorio earned a Bachelor of Science degree in Biology from Boston College.
  • Born: 1974
  • Holdings: none
  • Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.

Lina Karlsson

Board Member since 2021
LIna Karlsson

Lina Karlsson has demonstrated significant success with product development and organizational development in the medical industry. Experienced in several areas such as R&D, strategy, and operations, she has a proven track record in operational excellence work with a focus on cost reductions and quality improvements and a strong interest in organizational optimization, business development, and general management.

She holds the position as Director R&D, Surgical Solutions for Mölnlycke Healthcare but is currently moving into a new role as Executive VP for Business area Antiseptics in the same company. After completing post-doctorate work at Astra Zeneca she joined Gambro AB where she held several leadership roles in Global R&D and Operations. After integration to Baxter, she joined the global R&D team where held the position of Director Renal R&D, HD Therapy, and site manager for the Baxter Lund R&D site.

  • Other appointments: none
  • Education: Ms. Karlsson attended Lund University where she received a Master’s degree in Chemical Engineering and a PhD in Polymer Science and Engineering. She received an Executive MBA from the Executive Foundation Lund and is currently enrolled there as well in the Board of Directors training program
  • Born: 1973
  • Holdings: none
  • Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.

Fredrik Lindgren

Board Member since 2024

Fredrik Lindgren

Fredrik Lindgren has over 25 years of experience in the Life Science sector, where he has served as a CEO or board member in more than 10 different companies. He served as the Managing Director at Larodan AB until 2023, and previously, he held the role as CEO at Karo Pharma AB and Biolin Scientific AB.


  • Other appointments: Chairman and owner of Magbaleo AB, Bergslagernas Järnvaruaktiebolag, Sandlund Hossain AB, and member of the Board of AroCell AB and Lipigon AB.
  • Education: Mr. Lindgren holds a law degree from Lund University and an eMBA from Stockholm School of Economics.
  • Born: 1971
  • Holdings: 1 856 489 shares (owned through company)
  • Independence: Independent of executive management but not independent of major shareholder.

Hope Rugo

Board Member since 2024

Hope S. Rugo, MD, FASCO, is professor of medicine in the Division of Hematology and Oncology at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, where she is also the director of Breast Oncology and Clinical Trials Education. Dr. Rugo joined the Breast Care Center in 1999 after a decade of experience at University of California San Francisco in malignant hematology and bone marrow transplantation for a variety of diseases, including breast cancer. She entered the field of breast cancer in order to incorporate novel therapies based on an understanding of the biology of cancer with excellent quality of care into the treatment of women with breast cancer. As an internationally recognized clinician and researcher, she was the principal investigator on the DigniCap multi-center pivotal trial which introduced scalp cooling to the United States and led to FDA clearance for DigniCap in 2015.

  • Other appointments: none
  • Education: Dr. Rugo received her MD degree from University of Pennsylvania School of Medicine; Residency at UCSF Medical Center Internal Medicine, Fellowship at UCSF Medical Center, Hematology and Oncology; Board Certifications in Internal Medicine, American Board of Internal Medicine and Medical Oncology, American Board of Internal Medicine.
  • Holdings: none
  • Independence: Independent in relation to the company, the company’s senior executives and major shareholders of the company.

Chief Executive Officer

Fredrik Jonsson is an accomplished leader with a focus on entrepreneurship, sales, marketing, and strategy. With extensive experience in both large and small MedTech organizations, Fredrik brings valuable expertise to the Company. He comes most recently from the role as CEO of Spotlight-listed Alteco Medical AB, was previously CEO of Distributed Medical AB, and has held senior positions in companies operating in the fields of endoscopy with Medicinsk Bildteknik, and in dentistry with Distributed Medical, Ospol, DPNOVA, and other companies.

  • Joined Dignitana: 2024
  • Education: Technical college in Malmö; Programs in Business Management, Business Finance, Sales Management and Strategic Marketing at Cultivator
  • Holdings: None
  • Other appointments: None
  • Born: 1970


Chief Financial Officer

Ulf Jönsson has over 20 years of finance experience in multiple sectors including healthcare, technology, and manufacturing. He was most recently Interim Group Operations Controller for Diab International AB and was previously CFO for MalmbergGruppen, Swedish Agro Machinery and FrontPac. He spent 10 years with global med tech Gambro AB as Controller in various positions prior to the Company’s 2013 acquisition by Baxter.

  • Joined Dignitana: 2022
  • Education and Selected Training: Master in Business Administration from the University of Lund. University Certificate for Mechanical Engineering from The Faculty of Engineering at Lund University.
  • Holdings: 8 817
  • Other appointments: None
  • Born: 1971


Chief Communications Officer

Melissa Bourestom has over 25 years of experience in communications, marketing, and sales, with expertise is in developing clear, concise messaging tailored to the audience and aligned with strategic objectives. She has been recognized for building strong customer relationships and effective utilization of traditional and digital technologies. Prior to joining Dignitana she served as Executive Director of the American Advertising Federation Dallas and directed marketing and sales for myFootpath, an education technology platform. Ms. Bourestom previously worked in sales for Brinker International, in account management at Spier Advertising NY, and in clinical services and pediatric neurology at Children’s Medical Center Dallas.

  • Joined Dignitana: 2016
  • Education: BA in International Communications from Vanderbilt University;  Publishing Institute at New York University; Women’s Leadership Program at Kellogg School of Management, Northwestern University
  • Holdings: 5 000
  • Other appointments: None
  • Born: 1967



Director, Global Clinical Operations

Strong relationships, customer service, and clinical expertise are all hallmarks of Crista’s career and continue to be the foundation of the value the company provides to our clinical partners.

  • Joined Dignitana: 2017
  • Education: BSN Baylor University, MS Texas Women’s University
  • Holdings: None
  • Other appointments: None
  • Born: 1978


Vice President Operations, Research and Development

Before coming to Dignitana, Johan Johansson worked at Additude AB supporting all stages of medical device development including medical device regulation and regulatory compliance. Previously he oversaw the development of three medical devices as Chief Technical Officer at BrainCool AB, which was a subsidiary of Dignitana AB until 2014. Prior to BrainCool, Mr. Johansson held various roles in Engineering, Research and Development at Baxter, Krohne and Gambro.

  • Joined Dignitana: 2022
  • Education: Master of Science in Engineering from Lund University
  • Holdings: None
  • Other appointments: none
  • Born: 1973



VP Quality Affairs and Regulatory Affairs

Niklas Lindgren has over 20 years of experience in the Life Science and Technology fields. He was Senior Manager of Quality Affairs for Baxter Healthcare and held several roles in Quality, Quality Engineering and Production at Gambro Lundia AB, in addition to serving as Quality Engineer at Anoto AB. Mr. Lindgren’s diverse operational experience in highly regulated environments, combined with a practical understanding of the associated production, quality, and regulatory issues are a tremendous asset to Dignitana.

  • Joined Dignitana: 2022
  • Education: ISO 13485:2003, Semko; Quality System Requirements and Industry Practice, AAMI; UGL Swedish Armed Forces Leadership Training, UGIL; Leadership fundamentals, Krauthammer International; Pauliskolan Technical completion in Mechanics; Polhemskolan Technical Coursework in Operation and Maintenance
  • Holdings: None
  • Other appointments: None
  • Born: 1972


Executive Vice President Business Development & Sales -United States

Cameron O’Mara brings extensive experience originating new market opportunities for innovative products and services globally. After beginning his career at Arena Capital Partners LP, a middle-market private equity firm in New York City, Mr. O’Mara co-founded several global clean drinking water companies. As part of his duties, he spearheaded project development efforts across over twenty emerging markets; establishing partnerships and formal dialogue with local influencers and government officials throughout. He was invited to discuss creative solutions to improve fresh drinking water supplies and associated health standards with Heads of State and senior government ministers across three different continents.

  • Joined Dignitana: 2019
  • Education: BA in Psychology from Harvard University
  • Holdings: None
  • Other appointments: None
  • Born: 1979


Vice President Business Development & Sales – Europe & Rest of World

Selma Radovac began her MedTech career at Össur as Marketing Manager and later as a Market Analyst. She’s served as a Senior Account Manager and Interim Manager at Gartner, collaborating with high-growth technology providers in the Nordics. Subsequently, Selma led European Operations for MINDBODY Inc, managing a team of 90+ employees across Sales, Marketing and Operations. Selma ran her own management consultancy that helped SaaS companies scale. She holds MSc in International Business and Economics and MSc in Peace and Development studies. Selma is also a certified Leadership and Transformational Coach, having obtained her diploma form The Coaching Academy in London.

  • Joined Dignitana: 2023
  • Education: MSc International Business and Economics Växjö University; MSc Peace and Development, Växjö University; Leadership and Transformational Coaching Diploma, The Coaching Academy, London.
  • Holdings: None
  • Other appointments: None
  • Born: 1982

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

Dignitana S.r.l.
Corso di Porta Nuova, 46
20121 Milan, Italy